Prof. Yoshikazu Yonemitsu will present at the 31st Annual Meeting of Japan Society of Gene and Cell Therapy

Fukuoka, JAPAN – Prof. Yoshikazu Yonemitsu, MD PhD, CSO/CMO of GAIA BioMedicine, will present on the Clinical Development of GAIA-102 at the 31st Annual Meeting of Japan Society of Gene and Cell Therapy.

Presentation Information:

Session: JSGCT-JSRM Joint Symposium
Title: Clinical development of NK-like cells, GAIA-102, that can eliminate solid tumors
Scheduled for: July 23, 2025, 14:10~15:10 (JST), HOTEL GAJOEN TOKYO, Hall 1 (Maiougi)

Seminar Information:

Session: Luncheon Seminar 6
Title: R&D for GAIA-102, a novel NK-like phenotype that can eliminate solid tumors
Scheduled for: July 24, 2025, 11:40~12:40 (JST), HOTEL GAJOEN TOKYO, Hall 3 (Hana shirabe)

About The Japan Society of Gene and Cell Therapy

The Japan Society of Gene and Cell Therapy was established in 1994, and it is one of the oldest societies in the world in this field. The mission of this society is to advance the field of gene and cell therapy through interdisciplinary research and the training of scientists, ultimately contributing to the betterment of human health and welfare.

https://square.umin.ac.jp/jsgct2025/

Share on